The CD94/NKG2 C-type lectin receptor complex: Involvement in NK cell-mediated recognition of HLA class I molecules

Immunologic Research

Volumn 16, Issue 2, 1997, Pages 175-185

  López Botet, Miguel ^a,b   Carretero, Marta ^a   Pérez Villar, Juan J ^a   Bellón, Teresa ^a   Llano, Manuel ^a   Navarro, Francisco ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Cytotoxicity; MHC; NK cells; Receptor

Indexed keywords

CD94 ANTIGEN; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; LECTIN RECEPTOR; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ARTICLE; MULTIGENE FAMILY; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0030847106     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786361     Document Type: Article

References (51)

1. Ljunggren H-G, Kärre K: In search of the missing self: MHC molecules and NK-cell recognition. Immunol Today 1990;11:237-244.
2. Yokoyama WM: Natural killer cell receptors. Curr Opin Immunol 1995;7:110-120.
3. Lanier LL, Phillips JH: Inhibitory MHC class I receptors on NK-cells and T-cells. Immunol Today 1995; 17:86-91.
4. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L: Receptors for HLA class I molecules in human natural killer cells. Annu Rev Immunol 1996;14:619-648.
5. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO: Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995;267:1016-1018.
6. Peruzzi M, Parker KC, Long EO, Malnati MS: Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol 1996;157: 3350-3356.
7. Melero I, Salmeró;n A, Balboa MA, Aramburu J, Ló;pez-Botet M: Tyrosine kinase-dependent activation of human NK-cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. J Immunol 1994;152:1662-1673.
8. Döring C, Samaridis J, Colonna M: Alternatively sipliced forms of human killer inhibitory receptors. Immunogenetics 1996;3:227-230.
9. Bottino C, Sivori S, Vitale M, Cantoni C, Falco M, Pende D, Morelli L, Augugliaro R, Semenzato G, Biassoni R, Moretta L, Moretta A: A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol 1996;26:1816-1824.
10. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, Di Donato C, Accame O, Bottino C, Moretta A, Moretta L: The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/ p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kDa disulphide-linked dimer. J Exp Med 1996;184:505-518.
11. Döhring C, Scheidegger D, Samaridis J, Cella M, Colonna M: A human killer inhibitory receptor specific for HLA-A: J Immunol 1996;156:3098-3101.
12. Lanier LL, Gumperz JE, Parham P, Melero I, López-Botet M, Phillips JH: The NKB1and HP-3E4 NK-cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol 1995;154: 3320-3327.
13. Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet J-P, Long EO: Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 1996;4:77-85.
14. Campbell KS, Dessing M, López-Botet M, Cella M, Colonna M: Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med 1996; 184: 93-100.
15. Fry A, Lanier LL, Weiss A: Phosphotyrosines in the KIR motif of NKB1 are required for negative signaling and for association with PTPlC. J Exp Med 1996;184: 295-300.
16. Olcese L, Lang P, Vely F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni R, Moretta A, Moretta L, Cambier JC, Vivier E: Human and mouse killer-cell inhibitory receptors recruit PTP1-C and PTP1-D protein tyrosine phosphatases. J Immunol 1996;156: 4531-4534.
17. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C moleculesin human natural killer cells: J Exp Med 1995;182:875-884.
18. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L: The HLA-C specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996;183: 645-650.
19. Ló;pez-Botet M, Moretta L, Strominger JL: NK-cell-receptors and recognition of MHC class-I molecules. Immunol Today 1996;17: 212-214.
20. Lanier LL, Chang C, Phillips JH: Human NKR-P1A: A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 1994;153:2417-2428.
21. Düchler M, Offterdinger M, Holzmüller H, Lipp J, Chu C-T, Aschauer B, Bach FH, Hofer E: NKG2-C is a receptor on human natural killer cells that recognizes structures on K562 target cells. Eur J Immunol 1995;25:2923-2931.
22. Houchins JP, Yabe T, McSherry C, Bach FH: DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 1991;173:1017-1020.
23. Yabe T, McSherry C, Bach FH, Fisch P, Schall RP, Sondel PM, Houchins JP: A multigene family on human chromosome 12 encodes natural killer cell-lectins. Immunogenetics 1993;37:455-460.
24. Adamkiewicz TV, McSherry C, Bach FH, Houchins JP: Natural killer lectin-like receptors have divergent carboxy-termini distinct from C-type lectins. Immunogenetics 1994;39:218-223.
25. Chang C, Rodríguez A, Carretero M, Ló;pez-Botet M, Phillips J, Lanier LL: Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 1995;25:2433-2437.
26. López-Cabrera M, Santis AG, Fernandez-Ruiz E, Blacher R, Esch F, Sánchez-Mateos P, Sanchez-Madrid F: Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med 1993;178:537-547.
27. Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, Barbaresi M, Pende D, Ciccone E, López-Botet M, Moretta L: Human natural killer cell receptors for HLA-class I molecules: Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 1994; 180:545-555.
28. Sivori S, Vitale M, Bottino C, Marcenato E, Sanseverino L, Parolini S, Moretta L, Moretta A: CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alelles: Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur J Immunol 1996;26:2487-2492.
29. Phillips JH, Chang C, Mattson J. Gumperz JE, Parham P, Lanier LL: CD94 and a novel associated protein (94AP) form a NK-cell receptor involved in the recognition of HLA-A, -B. and -C allotypes. Immunity 1996;5:163-172.
30. Aramburu J, Balboa MA, Ramírez A, Silva A, Acevedo A, Sánchez-Madrid F, de Landázuri MO, López-Botet M: A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T-cell receptor-γ/δ+ T lymphocytes. Inhibition of IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol 1990; 144:3238-3247.
31. López-Botet M: CD94 cluster report: overview of the characterization of the Kp43 NK-cell-associated surface antigen; in Schlossman SF et al. (eds): Leucocyte Typing V. Oxford, UK, Oxford University Press, 1995, pp 1437-1439.
32. Acevedo A, Aramburu J, López J, Fernández-Herrera J, Fernández-Rañada JM, López-Botet M: Identification of natural killer (NK) cells in lesions of human cutaneous graft-versus-host disease: expression of a novel NK-associated surface antigen (Kp43) in mononuclear infiltrates. J Invest Dermatol 1991;97:659-666.
33. Mincheva-Nilsson L, Hammarström S, Hammarström ML: Human decidual leucocytes from early pregnancy contain high numbers of γδ+ cells and show selective down-regulation of alloreactivity. J Immunol 1992; 149:2203-2211.
34. Gudelj L, Deniz G, Rukavina D, Johnson PM, Christmas SE: Expression of functional molecules by human CD3- decidual granular leucocyte clones. Immunology 1996;87:609-615.
35. Pérez-Villar JJ, Melero I, Rodríguez A, Carretero M, Aramburu J, Sivori S, Orengo AM, Moretta A, López-Botet M: Functional ambivalence of the Kp43 (CD94) NK-cell-associated surface antigen. J Immunol 1995;154:5779-5788.
36. Brumbaugh KM, Pérez-Villar JJ, Dick CJ, Schoon R, López-Botet M, Leibson PJ: Clonotypic differences in signaling from CD94 (Kp43) on NK-cells lead to divergentcellular responses. J Immunol 1996;157:2804-2812.
37. Pérez-Villar JJ, Carretero M, Navarro F, Melero I, Rodríguez A, Bottino C, Moretta A, López-Botet: Biochemical and serological evidence for the existence of functionally distinct isoforms of the CD94 NK-cell receptor. J Immunol 1996;157:5367-5374.
38. Rodríguez A, Corbi A, López-Botet M: Identification of new cDNA sequences belonging to the NKG2 family of genes expressed in NK-cells. Nat Immun 1992; 11:262.
39. Carretero M, Cantoni C, Bellón T, Bottino C, Biassoni R, Rodríguez A, Pérez-Villar J.J., Moretta L, Moretta A, López-Botet M: The CD94 and NKG2-A C-type lectins covalently assemble to form an NK-cell inhibitory receptor for HLA class I molecules. Eur J Immunol 1997;27:563-567.
40. Plougastel B, Jones T, and Trowsdale J: Genomic structure, chomosome location and alternative splicing of the human NKG2-A gene. Immunogenetics 1996;44: 286-288.
41. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH: Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 1996;157:4741-4745.
42. 41a Pérez-Villar J, Melero I, Navarro F, Cazzetero M, Bellén T, Llano M, Colonna M, Geraghty DE, López-Botet M: The CD94/MK62-A inhibitory receptor complex is involved in NK cell-mediated recognition of cells expressing HLA-Gl. J Immunol, in press.
43. Pazmany L, Mandelboim O, Valés-Gomez M, Davis DM, Reyburn HT, Strominger JL: Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996;274: 792-794.
44. Daniels BF, Nakamura MC, Rosen SD, Yokoyama WM, Seaman WE: Ly-49A, a receptor for H-2Dd, has a functional carbohydrate recognition domain. Immunity 1995;1:785-792
45. Correa I, Raulet, DH: Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 1995;2:61-71.
46. Storkus WJ, Salter RD, Cresswell P, Dawson JR: Peptide modulation of target sensitivity to natural killing. J Immunol 1992;149: 1185-1190.
47. Aramburu J, Balboa MA, Izquierdo M, López-Botet M: A novel functional cell surface dimer (Kp43) expressed by natural killer cells and γ/δ+ T lymphocytes. Modulation of natural killer cytotoxicity by anti Kp43 monoclonal antibody. J Immunol 1991;147:714-721.
48. Aramburu J, Balboa MA, Rodríguez A, Melero I, Alonso M, Alonso JL, López-Botet M: Stimulation of IL-2-activated natural killer cells through the Kp43 surface antigen up-regulates TNF-α production involving the LFA-1 integrin. J Immunol 1993;151: 3420-3429.
49. Balboa MA, Balsinde J, Aramburu J, Mollinedo F, López-Botet M: Phospholipase Dactivation in human natural killer cells through the Kp43 and CD16 surface antigens takes place by different mechanisms. Involvement of the Phospholipase D pathway in tumor necrosis factor a synthesis. J Exp Med 1992;176:9-17.
50. Collins TL, Kassner PD, Bierer B, Burakoff SJ: Adhesion receptors in lymphocyte activation. Curr Opin Immunol 1994;6:385-393.
51. Thomas ML: Of ITAMs and ITIMs. Turning on and off the B cell antigen receptor. J Exp Med 1995;181:1953-1956.